Literature DB >> 7506695

Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease.

B R Yacyshyn1, L M Pilarski.   

Abstract

Crohn's disease is an immunoregulatory disorder of the intestine that can be associated with systemic manifestations. This study analysed B-cell differentiation antigens to identify B-cell subpopulations unique to patients with Crohn's disease. CD45 isoform expression was used as an indicator of B-cell differentiation stage. This work shows that B-cells in blood and gut of patients with Crohn's disease are at an advanced stage of differentiation based on their unusual presentation of transitional (RA+ RO+) and late stage (RO+)CD45 isoforms on lamina propria lymphocytes, whereas normal intestinal lamina propria lymphocytes B-cells express primarily CD45RA. Crohn's disease patients had heightened expression of the CD45RO isoform on CD19+ lamina propria lymphocytes, and was found in a statistically significant proportion of Crohn's peripheral blood mononuclear cells (PBMC) where CD19+ PBMC had an expression pattern affecting an unexpectedly high proportion of these differentiated or late stage CD45RO+ B-cells. The expression of CD45RO varied greatly among CD19+ PBMC from patients with Crohn's disease, so multiple regression analysis was performed between these CD45 isoforms and several clinical parameters. After grouping high and low CD45RO expression on CD19+ B-cells, a significant statistical difference was found between high Crohn's disease activity index (CDAI) and low CDAI Crohn's disease patients respectively.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506695      PMCID: PMC1374466          DOI: 10.1136/gut.34.12.1698

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

Review 1.  The leukocyte common antigen family.

Authors:  M L Thomas
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

Authors:  F Pallone; S Fais; O Squarcia; L Biancone; P Pozzilli; M Boirivant
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

3.  Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.

Authors:  H M Serra; J F Krowka; J A Ledbetter; L M Pilarski
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

4.  Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients.

Authors:  S P James; C Fiocchi; A S Graeff; W Strober
Journal:  Gastroenterology       Date:  1986-12       Impact factor: 22.682

5.  Alterations of IgM, IgG, and IgA Synthesis and secretion by peripheral blood and intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Authors:  R P MacDermott; G S Nash; M J Bertovich; M V Seiden; M J Bragdon; M G Beale
Journal:  Gastroenterology       Date:  1981-11       Impact factor: 22.682

6.  Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease.

Authors:  A Raedler; S Fraenkel; G Klose; K Seyfarth; H G Thiele
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

7.  Raised serum levels of IgM-rheumatoid factor and anti-F(ab')2 autoantibodies in patients with active inflammatory bowel disease.

Authors:  F Pallone; P M Matricardi; O Squarcia; S Fais; S Le Moli; M Boirivant; P Paoluzi; R D'Amelio
Journal:  J Clin Lab Immunol       Date:  1986-04

8.  Circulating lymphocyte subpopulations in Crohn's disease.

Authors:  S Z Yuan; S B Hanauer; L F Kluskens; S C Kraft
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

9.  Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease.

Authors:  R P MacDermott; G S Nash; M J Bertovich; R F Mohrman; I J Kodner; D L Delacroix; J P Vaerman
Journal:  Gastroenterology       Date:  1986-08       Impact factor: 22.682

10.  Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens.

Authors:  M Streuli; C Morimoto; M Schrieber; S F Schlossman; H Saito
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

View more
  3 in total

1.  Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability.

Authors:  B Yacyshyn; J Meddings; D Sadowski; M B Bowen-Yacyshyn
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

2.  Induction of B cell responses upon experimental infection of neonatal calves with Mycobacterium avium subsp. paratuberculosis.

Authors:  J R Stabel; J P Bannantine; Shigetoshi Eda; S Robbe-Austerman
Journal:  Clin Vaccine Immunol       Date:  2011-05-04

3.  Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases.

Authors:  Samuel J S Rubin; Lawrence Bai; Yeneneh Haileselassie; Gotzone Garay; Chohee Yun; Laren Becker; Sarah E Streett; Sidhartha R Sinha; Aida Habtezion
Journal:  Nat Commun       Date:  2019-06-19       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.